Position in ANVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$17,470
-$3,476 QoQ
Shares Held
9,393
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 61 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $11,168,948 across 32 Biotechnology names. ANVS ranks #12 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
108,446 | $6,080,566 | |
| 2 | ABSI |
Absci Corp
|
189,522 | $2,196,559 | |
| 3 | TECH |
BIO-TECHNE Corp
|
28,159 | $1,989,433 | |
| 4 | ARGX |
Argenx SE
|
239 | $221,736 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
370 | $183,789 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
393 | $146,066 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
106 | $66,095 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
1,633 | $60,763 |
All Filings in ANVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,470 | 9,393 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $20,946 | 9,393 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $32,499 | 9,393 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $19,443 | 9,393 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $20,382 | 9,393 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $14,089 | 9,393 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $47,246 | 9,393 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $75,707 | 9,393 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $298,227 | 9,393 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $803,852 | 9,393 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $408,539 | 14,643 | Shares | Sole | 2021-04-23 | |
| No filing history on record for this holder in this stock. | ||||||